MCRB vs TER · rev $1.1M vs P/E 76, rev $2.61B
Seres Therapeutics Inc (MCRB) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
Latest reported TER revenue for 2026-06-28 was $2.61B. Net income was $773.4M. TER currently screens at market cap $63.96B and trailing P/E 75.7.
MCRB currently screens at market cap $109.8M. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the MCRB and TER stock pages for the full models.
Not investment advice.